Skip to main content
. 2015 Feb 27;172(6):1494–1504. doi: 10.1111/bph.12825

Figure 6.

Figure 6

Treatment with STS and NaHS prevents the up-regulation of fibronectin and galectin-3. (A) Fibronectin and (B) galectin-3 mRNA levels were 4.3-fold and 3.2-fold increased in Ang II-infused animals treated with vehicle (n = 7) respectively. In STS- (n = 7) and NaHS-treated (n = 6) animals, no increase in fibronectin and galectin-3 mRNA levels were observed. (###P < 0.001 vs. control, **P < 0.01, *P < 0.05 vs. Ang II + NaCl). Fibronectin and galectin mRNA levels were normalized to GAPDH.